Rabishield: First fast-acting anti-rabies drug set for India launch

RMAb has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical School.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news